Trans-Tasman Mutual Recognition (South Australia) Regulations 2013 (SA)

South Australia

Trans-Tasman Mutual Recognition (South Australia) Regulations 2013

under the Trans-Tasman Mutual Recognition (South Australia) Act 1999

Contents

1            Short title

3            Interpretation

4            Temporary exemptions—synthetic drugs

Legislative history

1—Short title

These regulations may be cited as the Trans-Tasman Mutual Recognition (South Australia) Regulations 2013.

3—Interpretation

In these regulations, unless the contrary intention appears—

Act means the Trans-Tasman Mutual Recognition (South Australia) Act 1999.

4—Temporary exemptions—synthetic drugs

(1)For the purposes of section 5 of the Act and section 46 of the Commonwealth Act, the substances specified in subregulation (4) are declared to be exempt from the operation of the Commonwealth Act.

(2)For the purposes of section 5 of the Act and section 46 of the Commonwealth Act, the provisions of the Controlled Substances (Controlled Drugs, Precursors and Plants) Regulations 2000 inserted by the Controlled Substances (Controlled Drugs, Precursors and Plants) (Synthetic Controlled Drugs) Variation Regulations 2013 are declared to be to be exempt from the operation of the Commonwealth Act.

(3)The exemptions from the Commonwealth Act under this regulation have effect for a period of 12 months following the commencement of this regulation.

(4)The following substances and any preparation containing 1 or more of the following substances are specified for the purposes of subregulation (1):

(a)5-(2-aminopropyl)benzofuran (5‑APB);

(b)6-(2-aminopropyl)benzofuran (6‑APB);

(c)(RS)-2-ethylamino-1-(4-methylphenyl)propan-1-one (4‑methylethcathinone or 4‑MEC);

(d)1-phenyl-2-(methylamino)pentan-1-one (pentedrone);

(e)(RS)-1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha‑PVP or alpha‑pyrrolidinovalerophenone);

(f)1-(thiophen-2-yl)-2-methylaminopropane (methiopropamine);

(g)2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine);

(h)arylcyclohexylamines;

(i)2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2‑methoxyphenyl)methyl]ethanamine (25B‑NBOMe);

(j)2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C‑NBOMe);

(k)2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I‑NBOMe);

(l)1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H‑indazole‑3‑carboxamide (APINACA or AKB48);

(m)(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3‑tetramethylcyclopropyl)methanone (XLR‑11);

(n)(1-pentylindol-3-yl)-(2,2,3,3‑tetramethylcyclopropyl)methanone (UR‑144);

(o)4-Hydroxybutanoic acid lactone (GBL).

Legislative history

Notes

•For further information relating to the Act and subordinate legislation made under the Act see the Index of South Australian Statutes or of regulations

The Trans-Tasman Mutual Recognition (South Australia) Regulations 2013 were revoked by Sch 2 of the Trans-Tasman Mutual Recognition (South Australia) Regulations 2015 on 23.7.2015.

Legislation revoked by principal regulations

The Trans-Tasman Mutual Recognition (South Australia) Regulations 2013 revoked the following:

Trans-Tasman Mutual Recognition (South Australia) Regulations 1999

Principal regulations and variations

Year	No	Reference	Commencement
2013	235	Gazette 19.9.2013 p3871	19.9.2013: r 2
2013	242	Gazette 24.10.2013 p4091	24.10.2013: r 2

Provisions varied

Entries that relate to provisions that have been deleted appear in italics.

Provision	How varied	Commencement
r 2	omitted under Legislation Revision and Publication Act 2002	24.10.2013
r 4
r 4(4)	varied by 242/2013 r 4(1)—(3)	24.10.2013
Sch 1	omitted under Legislation Revision and Publication Act 2002	24.10.2013